ArticleFrontiers in bioengineering and biotechnology2026
A pre-market, open-label, single-arm study to evaluate b.Bone for posterolateral fusion treatment of degenerative thoracolumbar, lumbar or lumbosacral spinal disease (b.Spine clinical trial).
Giuseppe Tedesco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.